EAM
Eventide Asset Management’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-180,857
| Closed | -$22.8M | – | 160 |
|
|
2023
Q4 | $22.8M | Sell |
180,857
-394,581
| -69% | -$49.7M | 0.37% | 79 |
|
|
2023
Q3 | $53.9M | Buy |
575,438
+6
| +0% | +$562 | 0.97% | 35 |
|
|
2023
Q2 | $51.4M | Sell |
575,432
-207,408
| -26% | -$18.5M | 0.87% | 40 |
|
|
2023
Q1 | $83.9M | Buy |
782,840
+131
| +0% | +$14K | 1.54% | 17 |
|
|
2022
Q4 | $95.6M | Sell |
782,709
-416,291
| -35% | -$50.8M | 1.89% | 16 |
|
|
2022
Q3 | $124M | Hold |
1,199,000
| – | – | 2.44% | 3 |
|
|
2022
Q2 | $111M | Sell |
1,199,000
-130,432
| -10% | -$12.1M | 2.38% | 6 |
|
|
2022
Q1 | $156M | Sell |
1,329,432
-419,216
| -24% | -$49.2M | 2.44% | 3 |
|
|
2021
Q4 | $235M | Hold |
1,748,648
| – | – | 3.01% | 1 |
|
|
2021
Q3 | $279M | Buy |
1,748,648
+50,000
| +3% | +$7.97M | 3.68% | 1 |
|
|
2021
Q2 | $223M | Hold |
1,698,648
| – | – | 3% | 2 |
|
|
2021
Q1 | $219M | Sell |
1,698,648
-5,500
| -0.3% | -$709K | 3.24% | 2 |
|
|
2020
Q4 | $284M | Sell |
1,704,148
-5,700
| -0.3% | -$951K | 4.36% | 1 |
|
|
2020
Q3 | $264M | Hold |
1,709,848
| – | – | 5.17% | 1 |
|
|
2020
Q2 | $253M | Buy |
1,709,848
+11,200
| +0.7% | +$1.66M | 5.5% | 1 |
|
|
2020
Q1 | $191M | Hold |
1,698,648
| – | – | 6.19% | 1 |
|
|
2019
Q4 | $236M | Hold |
1,698,648
| – | – | 6.66% | 1 |
|
|
2019
Q3 | $164M | Hold |
1,698,648
| – | – | 5.41% | 1 |
|
|
2019
Q2 | $196M | Hold |
1,698,648
| – | – | 5.95% | 1 |
|
|
2019
Q1 | $200M | Hold |
1,698,648
| – | – | 6.88% | 1 |
|
|
2018
Q4 | $106M | Buy |
1,698,648
+153,748
| +10% | +$9.63M | 4.71% | 1 |
|
|
2018
Q3 | $109M | Buy |
1,544,900
+157,900
| +11% | +$11.2M | 4.02% | 1 |
|
|
2018
Q2 | $92.3M | Buy |
1,387,000
+54,460
| +4% | +$3.62M | 3.83% | 1 |
|
|
2018
Q1 | $87.1M | Hold |
1,332,540
| – | – | 4.08% | 1 |
|
|
2017
Q4 | $53.4M | Buy |
1,332,540
+128,000
| +11% | +$5.13M | 2.78% | 2 |
|
|
2017
Q3 | $43.7M | Buy |
1,204,540
+564,540
| +88% | +$20.5M | 2.47% | 6 |
|
|
2017
Q2 | $17.8M | Buy |
640,000
+393,900
| +160% | +$10.9M | 1.11% | 42 |
|
|
2017
Q1 | $6.89M | Buy |
246,100
+17,100
| +7% | +$479K | 0.46% | 59 |
|
|
2016
Q4 | $4.64M | Buy |
+229,000
| New | +$4.64M | 0.3% | 72 |
|